Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      FIRST: Intas Pharma launches Romiplostim to treat chronic ITP in India

      FIRST: Intas Pharma launches Romiplostim to treat chronic ITP in India

      Medical Dialogues Bureau12 July 2019 11:48 AM IST
      Romiplostim is one of the most efficacious agents with proven long-term benefits in chronic ITP, a release here said.Mumbai: Pharma Major, Intas...
      Piramal cuts short-term borrowings, reduces dependence on CPs as NBFC crisis lingers

      Piramal cuts short-term borrowings, reduces dependence on CPs as NBFC crisis lingers

      Medical Dialogues Bureau12 July 2019 9:15 AM IST
      Piramal Enterprises chairman Ajay Piramal in his address to the shareholders in the FY19 annual report said the company continues to build resilience...
      Sterling Group: Government scraps Dahej port contract given to absconding Sandesara brothers

      Sterling Group: Government scraps Dahej port contract given to absconding Sandesara brothers

      Medical Dialogues Bureau12 July 2019 9:11 AM IST
      The absconding promoters of the Sterling group-- Nitin and Chetan Sandesara--are alleged to have defrauded over Rs 14,500 crore of public money. Two...
      Gilead Sciences chooses Chengdu Hi-tech Zone for Western China Operation Center project

      Gilead Sciences chooses Chengdu Hi-tech Zone for Western China Operation Center project

      Medical Dialogues Bureau12 July 2019 9:10 AM IST
      Established in 1987 and headquartered in California, Gilead Sciences is one of the top 10 pharmaceutical companies in the world. As a pioneer in...
      Trump administration scraps key plan to reduce US drug prices

      Trump administration scraps key plan to reduce US drug prices

      Medical Dialogues Bureau12 July 2019 9:00 AM IST
      The decision represents a new setback to U.S. President Donald Trump's efforts to deliver on a pledge to lower drug prices for consumers before the...
      Amazon Alexa to now offer medical advice for migraines, flu in UK

      Amazon Alexa to now offer medical advice for migraines, flu in UK

      Medical Dialogues Bureau11 July 2019 3:23 PM IST
      The US company's algorithm uses information from the NHS website to provide answers to voice questions such as "Alexa, how do I treat a migraine?" or...
      Torrent Pharma, Glenmark enter agreement to market Remogliflozin under trademark Zucator in India

      Torrent Pharma, Glenmark enter agreement to market Remogliflozin under trademark Zucator in India

      Medical Dialogues Bureau11 July 2019 10:00 AM IST
      "Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark 'Zucator' in India," Glenmark Pharma...
      Export-focused domestic pharma companies need to step up regulatory compliance: Report

      Export-focused domestic pharma companies need to step up regulatory compliance: Report

      Medical Dialogues Bureau11 July 2019 9:15 AM IST
      Mumbai: The US-focused domestic pharma companies need to step up regulatory compliance over the next decade and need to invest in complex generics and...
      Top China medical device manufacturer risks getting too pricey: Report

      Top China medical device manufacturer risks getting too pricey: Report

      Medical Dialogues Bureau11 July 2019 9:00 AM IST
      U.S: One of the biggest companies listed on southern China’s tech-heavy stock exchange is a fast-growing Chinese medical device maker that is grabbing...
      Chemist shop owner, associate held for selling psychotropic drugs to minors at inflated rates

      Chemist shop owner, associate held for selling psychotropic drugs to minors at inflated rates

      Medical Dialogues Bureau10 July 2019 2:53 PM IST
      "These injections were meant for relieving the pain of cancer patients. But the chemist shop owner and his associate were selling it to juveniles and...
      Dr Reddys launches OTC brand equivalent of Mucinex D ER tablets to treat phlegm

      Dr Reddys launches OTC brand equivalent of Mucinex D ER tablets to treat phlegm

      Medical Dialogues Bureau10 July 2019 10:04 AM IST
      The Mucinex D brand and store brands had combined US sales of approximately USD 71 million MAT (moving annual turnover) for the most recent 12 months...
      Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer

      Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer

      Medical Dialogues Bureau10 July 2019 10:00 AM IST
      Lupin's Imatinib Mesylate Tablets, 100mg (base) and 400mg (base), is the generic version of Novartis Pharmaceuticals Corporation's (Novartis) Gleevec...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok